Tag: MS

Teva questions safety of MS drug from rival Biogen

Your Health Matters

(Reuters) – Teva Pharmaceutical Industries Ltd, which makes the market-leading multiple sclerosis drug Copaxone, has filed a petition with the U.S. Food and Drug Administration that could, if granted, delay entry to the market of a rival drug developed by Biogen Idec Inc. Teva’s petition asks that the FDA not approve any new multiple sclerosis drug until its safety has been evaluated by a panel of outside advisors, and said it had uncovered “troubling information” on a publicly accessible website about the safety of Biogen’s drug, BG-12. …

, , ,

Journal questions use of cannabis spray drug for MS

Your Health Matters

The sun shines though the distinctive leaves of marijuana plants during police raid in the remote ...LONDON (Reuters) – There is little evidence to back the use of a cannabis extract spray made by GW Pharmaceuticals for spasticity in patients with multiple sclerosis, according to a medical journal review published on Thursday. GW Pharma said the report in the Drug and Therapeutics Bulletin (DTB), a British Medical Journal publication, gave "a misleading view of the drug" and contained a number of errors. Sativex is sold as a prescription drug in Britain by GW's partner, German group Bayer. …

,

Sanofi says MS treatment reduced relapse rate

Your Health Matters

PARIS (Reuters) – Sanofi said on Friday that a trial of its multiple-sclerosis treatment teriflunomide found that a daily dose of the drug reduced the annualized rate of relapse by 36 percent compared with a placebo. Teriflunomide, marketed as Aubagio, is one of the two multiple sclerosis drugs Sanofi has in late-stage development and one of several oral MS treatments being developed by major drug companies. (Reporting By Christian Plumb)

1 2 3